Product Details
Ruxolitinib for Tablets BP
Product Name
:
Ruxolitinib for Tablets BP
Brand Name
:
VERUXO
Available Strength
:
15 mg
Packing
:
60 Tablets
Pack Insert/Leaflet
:
According To Your Needs
These film-coated tablets meet British Pharmacopoeia standards, supporting targeted treatment for myeloproliferative disorders. Hematologists and oncologists prescribe Ruxolitinib to manage conditions such as myelofibrosis and polycythemia vera.
Ruxolitinib Phosphate BP (equivalent to Ruxolitinib 15 mg) is a Janus kinase (JAK1/JAK2) inhibitor that blocks the signaling pathways driving abnormal blood cell proliferation. As a result, it helps reduce spleen size and control disease-related symptoms. Because of this targeted mechanism, specialists prescribe it under close monitoring as part of an individualized treatment plan. Therefore, hospitals and hematology-oncology clinics rely on it for eligible patients under specialist care.
Key Features
- Meets BP (British Pharmacopoeia) standards for consistent quality
- Delivers targeted JAK1/JAK2 inhibition for myeloproliferative disorder management
- Ensures accurate, validated dosing in every batch
- Manufactured under GMP-compliant, high-alert medication handling protocols
- Intended strictly for use under specialist supervision
- Restricted to hospital, hematology-oncology clinic, and specialist institutional supply